» Articles » PMID: 36677534

Review and Chemoinformatic Analysis of Ferroptosis Modulators with a Focus on Natural Plant Products

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2023 Jan 21
PMID 36677534
Authors
Affiliations
Soon will be listed here.
Abstract

Ferroptosis is a regular cell death pathway that has been proposed as a suitable therapeutic target in cancer and neurodegenerative diseases. Since its definition in 2012, a few hundred ferroptosis modulators have been reported. Based on a literature search, we collected a set of diverse ferroptosis modulators and analyzed them in terms of their structural features and physicochemical and drug-likeness properties. Ferroptosis modulators are mostly natural products or semisynthetic derivatives. In this review, we focused on the abundant subgroup of polyphenolic modulators, primarily phenylpropanoids. Many natural polyphenolic antioxidants have antiferroptotic activities acting through at least one of the following effects: ROS scavenging and/or iron chelation activities, increased GPX4 and NRF2 expression, and LOX inhibition. Some polyphenols are described as ferroptosis inducers acting through the generation of ROS, intracellular accumulation of iron (II), or the inhibition of GPX4. However, some molecules have a dual mode of action depending on the cell type (cancer versus neural cells) and the (micro)environment. The latter enables their successful use (e.g., apigenin, resveratrol, curcumin, and EGCG) in rationally designed, multifunctional nanoparticles that selectively target cancer cells through ferroptosis induction.

Citing Articles

Targeting Ferroptosis in Rare Neurological Disorders Including Pediatric Conditions: Innovations and Therapeutic Challenges.

Alatawi A, Venkatesan K, Asseri K, Paulsamy P, Alqifari S, Ahmed R Biomedicines. 2025; 13(2).

PMID: 40002678 PMC: 11853599. DOI: 10.3390/biomedicines13020265.


Bee Pollen as a Source of Biopharmaceuticals for Neurodegeneration and Cancer Research: A Scoping Review and Translational Prospects.

Kacemi R, Campos M Molecules. 2025; 29(24).

PMID: 39769981 PMC: 11677910. DOI: 10.3390/molecules29245893.


EGCG activates Keap1/P62/Nrf2 pathway, inhibits iron deposition and apoptosis in rats with cerebral hemorrhage.

Hao L, Zhang A, Lv D, Cong L, Sun Z, Liu L Sci Rep. 2024; 14(1):31474.

PMID: 39732956 PMC: 11682079. DOI: 10.1038/s41598-024-82938-y.


Network Pharmacology and Metabolomics Reveal Anti-Ferroptotic Effects of Curcumin in Acute Kidney Injury.

Liu X, Zhou Y, Lu Z, Yang F, Wang Y, Zhang S Drug Des Devel Ther. 2024; 18:6223-6241.

PMID: 39722679 PMC: 11669278. DOI: 10.2147/DDDT.S486286.


Immunomodulatory and chemopreventive effects of resveratrol on the digestive system cancers.

Djaldetti M Oncol Res. 2024; 32(9):1389-1399.

PMID: 39220125 PMC: 11361903. DOI: 10.32604/or.2024.049745.


References
1.
Yaseen A, Yang F, Zhang X, Li F, Chen B, Hassan Ibrahim Faraag A . Ferroptosis inhibitory constituents from the fruits of . Nat Prod Res. 2020; 35(23):5364-5368. DOI: 10.1080/14786419.2020.1762188. View

2.
Mo Y, Duan L, Yang Y, Liu W, Zhang Y, Zhou L . Nanoparticles improved resveratrol brain delivery and its therapeutic efficacy against intracerebral hemorrhage. Nanoscale. 2021; 13(6):3827-3840. DOI: 10.1039/d0nr06249a. View

3.
Li R, Zhang J, Zhou Y, Gao Q, Wang R, Fu Y . Transcriptome Investigation and In Vitro Verification of Curcumin-Induced HO-1 as a Feature of Ferroptosis in Breast Cancer Cells. Oxid Med Cell Longev. 2020; 2020:3469840. PMC: 7691002. DOI: 10.1155/2020/3469840. View

4.
Fischer W, Currais A, Liang Z, Pinto A, Maher P . Old age-associated phenotypic screening for Alzheimer's disease drug candidates identifies sterubin as a potent neuroprotective compound from Yerba santa. Redox Biol. 2018; 21:101089. PMC: 6309122. DOI: 10.1016/j.redox.2018.101089. View

5.
Rauf A, Imran M, Ali Khan I, Ur-Rehman M, Gilani S, Mehmood Z . Anticancer potential of quercetin: A comprehensive review. Phytother Res. 2018; 32(11):2109-2130. DOI: 10.1002/ptr.6155. View